ALLOGENE THERAPEUTICS INC (ALLO) Stock Analyst Ratings
USA - NASDAQ:ALLO - US0197701065 - Common Stock
1.23 USD
-0.04 (-3.15%)
1.23 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 83% to ALLO. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 7.71. This target is 526.93% above the current price.
ALLO was analyzed by 20 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about ALLO.
In the previous month the buy percentage consensus was at a similar level.
ALLO was analyzed by 20 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-10-10 | JP Morgan | Downgrade | Neutral -> Underweight |
| 2025-08-04 | JMP Securities | Reiterate | Market Perform -> Market Perform |
| 2025-08-04 | JP Morgan | Downgrade | Overweight -> Neutral |
| 2025-05-15 | Citigroup | Maintains | Buy -> Buy |
| 2025-05-14 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-05-14 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2025-05-14 | Truist Securities | Maintains | Buy -> Buy |
| 2025-05-14 | Baird | Maintains | Outperform -> Outperform |
| 2025-05-14 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-03-19 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-03-14 | Citizens Capital Markets | Upgrade | Market Perform -> Market Outperform |
| 2025-03-14 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2025-03-14 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-11-14 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-11-08 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-30 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-09 | Truist Securities | Reiterate | Buy -> Buy |
| 2024-08-09 | Citigroup | Maintains | Buy -> Buy |
| 2024-08-08 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-05-31 | Piper Sandler | Initiate | Overweight |
| 2024-05-21 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-05-16 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-05-15 | Truist Securities | Maintains | Buy -> Buy |
| 2024-05-14 | Stifel | Maintains | Hold -> Hold |
| 2024-03-19 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-15 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-02-27 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-01-19 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-01-05 | Guggenheim | Downgrade | Buy -> Neutral |